BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35719323)

  • 1. Albumin Paclitaxel Compared with 5-Penfluorouracil, Lobaplatin, and Albumin Paclitaxel Combined with 5-Penfluorouracil in the Treatment of Human Gastric Cancer Cell AGS Line Autophagy and Apoptosis.
    Cheng X; Yang F; Wang Y; Nie W; Mahendra Upadhyay A; Zhang M; Wang Q; Yan Z
    Can J Gastroenterol Hepatol; 2022; 2022():6015877. PubMed ID: 35719323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer.
    Zhang C; Awasthi N; Schwarz MA; Hinz S; Schwarz RE
    PLoS One; 2013; 8(2):e58037. PubMed ID: 23460921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer.
    Zhang CΗ; Awasthi N; Schwarz MA; Schwarz RE
    Int J Oncol; 2013 Nov; 43(5):1627-35. PubMed ID: 24042258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.
    Kinoshita J; Fushida S; Tsukada T; Oyama K; Watanabe T; Shoji M; Okamoto K; Nakanuma S; Sakai S; Makino I; Furukawa H; Hayashi H; Nakamura K; Inokuchi M; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fujimura T; Masakazu Y; Hirakawa K; Ohta T
    Oncol Rep; 2014 Jul; 32(1):89-96. PubMed ID: 24859429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice.
    Zhang P; Lai ZL; Chen HF; Zhang M; Wang A; Jia T; Sun WQ; Zhu XM; Chen XF; Zhao Z; Zhang J
    J Exp Clin Cancer Res; 2017 Dec; 36(1):190. PubMed ID: 29273065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis.
    Ishikawa M; Iwasa S; Nagashima K; Aoki M; Imazeki H; Hirano H; Shoji H; Honma Y; Okita N; Takashima A; Kato K; Saruta M; Boku N
    Invest New Drugs; 2020 Apr; 38(2):533-540. PubMed ID: 31264067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing Efficacy of Albumin-Bound Paclitaxel for Human Lung and Colorectal Cancers through Autophagy Receptor Sequestosome 1 (SQSTM1)/p62-Mediated Nanodrug Delivery and Cancer therapy.
    Lin YW; Lin TT; Chen CH; Wang RH; Lin YH; Tseng TY; Zhuang YJ; Tang SY; Lin YC; Pang JY; Chakravarthy RD; Lin HC; Tzou SC; Chao JI
    ACS Nano; 2023 Oct; 17(19):19033-19051. PubMed ID: 37737568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial.
    Takashima A; Shitara K; Fujitani K; Koeda K; Hara H; Nakayama N; Hironaka S; Nishikawa K; Kimura Y; Amagai K; Fujii H; Muro K; Esaki T; Choda Y; Takano T; Chin K; Sato A; Goto M; Fukushima N; Hara T; Machida N; Ohta M; Boku N; Shimura M; Morita S; Koizumi W
    Gastric Cancer; 2019 Jan; 22(1):155-163. PubMed ID: 29855738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.
    Hirata K; Hamamoto Y; Ando M; Imamura CK; Yoshimura K; Yamazaki K; Hironaka S; Muro K
    BMC Cancer; 2020 Jun; 20(1):548. PubMed ID: 32532230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobaplatin inhibits growth of gastric cancer cells by inducing apoptosis.
    Yin CY; Lin XL; Tian L; Ye M; Yang XY; Xiao XY
    World J Gastroenterol; 2014 Dec; 20(46):17426-33. PubMed ID: 25516654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer Mechanism of Lobaplatin as Monotherapy and in Combination with Paclitaxel in Human Gastric Cancer.
    Hua S; Kong X; Chen B; Zhuang W; Sun Q; Yang W; Liu W; Zhang Y
    Curr Mol Pharmacol; 2018; 11(4):316-325. PubMed ID: 30101722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancer.
    Zhu M; Zhang P; Yu S; Tang C; Wang Y; Shen Z; Chen W; Liu T; Cui Y
    J Exp Clin Cancer Res; 2022 Jan; 41(1):14. PubMed ID: 34996504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role and mechanism research on reversal of 5-fluorouracil resistance by epigallocatechin gallate in gastric cancer drug-resistance cells lines SGC-7901/5-FU].
    Tang H; Zhang X; Cui S; Wang J; Ruan Q; Huang Y; Yang D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1170-1175. PubMed ID: 27781257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer.
    Kinoshita R; Ishima Y; Chuang VTG; Nakamura H; Fang J; Watanabe H; Shimizu T; Okuhira K; Ishida T; Maeda H; Otagiri M; Maruyama T
    Biomaterials; 2017 Sep; 140():162-169. PubMed ID: 28651144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chalcone flavokawain B induces autophagic-cell death via reactive oxygen species-mediated signaling pathways in human gastric carcinoma and suppresses tumor growth in nude mice.
    Chang CT; Hseu YC; Thiyagarajan V; Lin KY; Way TD; Korivi M; Liao JW; Yang HL
    Arch Toxicol; 2017 Oct; 91(10):3341-3364. PubMed ID: 28374157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic interaction between gefitinib (Iressa, ZD1839) and paclitaxel against human gastric carcinoma cells.
    Park JK; Lee SH; Kang JH; Nishio K; Saijo N; Kuh HJ
    Anticancer Drugs; 2004 Sep; 15(8):809-18. PubMed ID: 15494644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nab-paclitaxel interrupts cancer-stromal interaction through C-X-C motif chemokine 10-mediated interleukin-6 downregulation in vitro.
    Feng R; Morine Y; Ikemoto T; Imura S; Iwahashi S; Saito Y; Shimada M
    Cancer Sci; 2018 Aug; 109(8):2509-2519. PubMed ID: 29902349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TiO
    Azimee S; Rahmati M; Fahimi H; Moosavi MA
    Life Sci; 2020 May; 248():117466. PubMed ID: 32101760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CISD2 enhances the chemosensitivity of gastric cancer through the enhancement of 5-FU-induced apoptosis and the inhibition of autophagy by AKT/mTOR pathway.
    Sun Y; Jiang Y; Huang J; Chen H; Liao Y; Yang Z
    Cancer Med; 2017 Oct; 6(10):2331-2346. PubMed ID: 28857517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of paclitaxel on apoptosis, autophagy and mitotic catastrophe in AGS cells.
    Khing TM; Choi WS; Kim DM; Po WW; Thein W; Shin CY; Sohn UD
    Sci Rep; 2021 Dec; 11(1):23490. PubMed ID: 34873207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.